ALX Oncology Holdings Inc. ALXO

Full chart Compare
Set alert

Price alert · ALXO

All alert types
1.36 USD +0.07 (+5.43%)

At closeNov 4, 2026, 4:00 PM EST

1.36 0.00 0.00%

After hours · Nov 4, 4:00 PM ET

1.32 Day range 1.40
0.862 52-week range 2.66
YTD
+20.35%
1 year
-6.85%

Revenue & Expenses

Revenue → Gross Profit: $107.00KGross Profit → Expenses: $107.00KRevenue → Cost of Revenue: $1.07MExpenses → Selling, General & Admin: $14.81MExpenses → Research & Development: $28.96MExpenses → Other Expenses: $1.84MExpenses → Income Tax: $241.00KNet Loss → Expenses: $45.74MGross Profit$107.00KNet Loss$45.74MCost of Revenue$1.07MExpenses$45.85MSelling, General & Admin$14.81MResearch & Development$28.96MOther Expenses$1.84MIncome Tax$241.00KRevenue$1.18M

Latest period ending Dec 31, 2025 · select a line to chart its full history

ALXO annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-104.02M-142.47M-170.28M-127.44M-83.56M
-101.69M-134.85M-160.81M-123.48M-83.46M
-1.90-2.58-3.74-3.03-2.07
ALXO annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
16.37M17.57M22.41M48.82M363.67M
59.05M147.78M242.55M306.49M380.18M
33.06M34.16M52.84M43.02M17.13M
9.75M9.90M9.64M9.39M0
25.98M113.62M189.71M263.46M363.05M
ALXO annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-84.14M-121.91M-130.36M-89.22M-68.10M
82.59M86.26M44.66M-235.42M-4.92M
362.00K30.82M59.29M9.86M2.47M
-212.00K-447.00K-1.27M-1.43M-666.00K
-1.19M-4.84M-26.42M-314.78M-70.55M